🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Truist upgrades ARAMARK stock target, maintains buy rating post mixed Q4

EditorNatashya Angelica
Published 12/11/2024, 15:12
ARMK
-

On Tuesday, Truist Securities updated its outlook on ARAMARK Holdings (NYSE:ARMK) shares, increasing its price target to $46.00 from the previous $42.00 while maintaining a Buy rating on the stock. This adjustment comes as ARAMARK shares experienced an uptick following the release of its fourth fiscal quarter report and a forecast for the fiscal year 2025 that suggests slight growth.

The company's financial performance in the fourth fiscal quarter was described as mixed, but the guidance for fiscal year 2025 indicates a modest advantage.

The analyst at Truist Securities expressed a continued positive stance on ARAMARK's potential for valuation growth, noting that the stock is currently trading at a roughly 25% discount on an enterprise value to earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) basis compared to its closest peer, Compass Group (LON:CPG), which does not have a rating.

The optimism towards ARAMARK is further supported by the potential for market share increases, improvement in profit margins, and more manageable debt levels. These factors are expected to allow the company to engage in significant stock repurchases in fiscal year 2025, marking the first occasion for such activity in nearly eight years.

The analyst has chosen to keep the adjusted earnings per share (EPS) estimates for ARAMARK unchanged for both fiscal year 2025 and fiscal year 2026. The raised price target reflects confidence in the company's ability to improve its financial standing and reward its shareholders in the upcoming fiscal years.

In other recent news, Aramark has reported a robust financial performance for fiscal year 2024. The company saw a 10% year-over-year organic revenue growth, a 20% rise in adjusted operating income, and a 35% increase in adjusted EPS on a constant currency basis. Total (EPA:TTEF) revenue for the fiscal year reached $17.4 billion.

Moreover, Aramark announced a new $500 million share repurchase program, a clear indication of strong financial health. The company also secured $1.4 billion in new business and reported a 93.2% retention rate. For fiscal 2025, Aramark projects organic revenue growth of 7.5% to 9.5%, adjusted operating income growth of 15% to 18%, and adjusted EPS growth of 23% to 28%.

Baird recently maintained a Neutral rating on Aramark but raised the price target to $44. This decision followed Aramark's fourth quarter fiscal year 2024 results, which met expectations. The company's initial fiscal year 2025 guidance aligns with long-term targets, suggesting a year-over-year margin expansion of approximately 40 to 50 basis points.

InvestingPro Insights

To complement Truist Securities' optimistic outlook on ARAMARK Holdings (NYSE:ARMK), recent data from InvestingPro provides additional context for investors. ARAMARK's market capitalization stands at $10.19 billion, with a P/E ratio of 39.51, indicating that the stock is trading at a high earnings multiple. This valuation metric aligns with Truist's observation of a potential for valuation growth, despite the current discount compared to peers.

InvestingPro Tips highlight that ARAMARK has maintained dividend payments for 11 consecutive years, which may appeal to income-focused investors. Additionally, analysts predict the company will be profitable this year, supporting Truist's positive stance on the stock. However, it's worth noting that ARAMARK suffers from weak gross profit margins, with the latest data showing a gross profit margin of 8.19% for the last twelve months.

For investors seeking a more comprehensive analysis, InvestingPro offers 5 additional tips on ARAMARK, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.